Qiming Tan

Ms. Qiming Tan

University of Alberta, Edmonton, Alberta, Canada
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 May 2021 in Childhood Obesity
Verified
Journal Article
Open access
AHAndrea Haqq
Andrea Haqq
MKMaryam Kebbe
Maryam Kebbe
QTQiming Tan
Qiming Tan
MMMelania Manco
Melania Manco
XSXimena Ramos Salas
Ximena Ramos Salas
Weight stigma is rooted in a fundamental misunderstanding of the origins of obesity, wherein the interplay of behavioral, environmental, genetic, and metabolic factors is deemphasized. Instead, the widespread societal and cultural presence of weight stigma fosters misconceptions of obesity being solely a result of unhealthy personal choices. Weight stigma is pervasive in childhood and adolescence and can affect individuals throughout their life. Although the prevalence of pediatric obesity remains high throughout the world, it becomes increasingly important to understand how weight stigma affects weight and health outcomes in children and adolescents with overweight or obesity, including in those with rare genetic diseases of obesity. We identified and reviewed recent literature (primarily published since 2000) on weight stigma in the pediatric setting. Articles were identified with search terms including pediatric obesity, weight bias, weight stigma, weight-based teasing and bullying, and weight bias in health care. In this narrative review, we discuss the stigma of pediatric obesity as it relates to the complex etiology of obesity as well as describe best practices for avoiding bias and perpetuating stigma in the health care setting.

26 June 2021 in Autism Research
Verified
Journal Article
Closed access
PDF file
QTQiming Tan
Qiming Tan
COCamila E. Orsso
Camila E. Orsso
EDEdward C. Deehan
Edward C. Deehan
JKJanice Kung
Janice Kung
HTHein M. Tun
Hein M. Tun
AHAndrea Haqq
Andrea Haqq

30 December 2019 in Obesity Reviews
Verified
Journal Article
Closed access
PDF file
QTQiming Tan
Qiming Tan
COCamila Estefani Orsso
Camila Estefani Orsso
EDEdward C. Deehan
Edward C. Deehan
LTLucila Triador
Lucila Triador
CFCatherine Field
Catherine Field
AHAndrea Haqq
Andrea Haqq

25 January 2020 in Genes
Verified
Journal Article
Open access
PDF file
QTQiming Tan
Qiming Tan
KPKathryn J. Potter
Kathryn J. Potter
LBLisa Burnett
Lisa Burnett
COCamila Estefani Orsso
Camila Estefani Orsso
MIMark Inman
Mark Inman
AHAndrea Haqq
Andrea Haqq
We report a 17-year-old boy who met most of the major Prader–Willi syndrome (PWS) diagnostic criteria, including infantile hypotonia and poor feeding followed by hyperphagia, early-onset morbid obesity, delayed development, and characteristic facial features. However, unlike many children with PWS, he had spontaneous onset of puberty and reached a tall adult stature without growth hormone replacement therapy. A phenotype-driven genetic analysis using exome sequencing identified a heterozygous microdeletion of 71 kb in size at chr15:25,296,613-25,367,633, genome build hg 19. This deletion does not affect the SNURF-SNRPN locus, but results in the loss of several of the PWS-associated non-coding RNA species, including the SNORD116 cluster. We compared with six previous reports of patients with PWS who carried small atypical deletions encompassing the snoRNA SNORD116 cluster. These patients share similar core symptoms of PWS while displaying some atypical features, suggesting that other genes in the region may make lesser phenotypic contributions. Altogether, these rare cases provide convincing evidence that loss of the paternal copy of the SNORD116 snoRNA is sufficient to cause most of the major clinical features of PWS.

13 July 2021 in Microorganisms
Verified
Journal Article
Open access
PDF file
COCamila Estefani Orsso
Camila Estefani Orsso
YPYe Peng
Ye Peng
Edward C. DeehanEdward C. Deehan
Edward C. Deehan
QTQiming Tan
Qiming Tan
CFCatherine Field
Catherine Field
AHAndrea Haqq
Andrea Haqq
The gut microbiome is hypothesized to play a crucial role in the development of obesity and insulin resistance (IR); the pathways linking the microbiome to IR in pediatrics have yet to be precisely characterized. We aimed to determine the relationship between the gut microbiome composition and metabolic functions and IR in children with obesity. In a cross-sectional study, fecal samples from children with obesity (10–16 years old) were collected for taxonomical and functional analysis of the fecal microbiome using shotgun metagenomics. The homeostatic model assessment for insulin resistance (HOMA-IR) was determined using fasting glucose and insulin. Associations between HOMA-IR and α-diversity measures as well as metabolic pathways were evaluated using Spearman correlations; relationships between HOMA-IR and β-diversity were assessed by permutational multivariate analysis of variance. Twenty-one children (nine males; median: age = 12.0 years; BMI z-score = 2.9; HOMA-IR = 3.6) completed the study. HOMA-IR was significantly associated with measures of α-diversity but not with β-diversity. Children with higher HOMA-IR exhibited lower overall species richness, Firmicutes species richness, and overall Proteobacteria species Shannon diversity. Furthermore, HOMA-IR was inversely correlated with the abundance of pathways related to the biosynthesis of lipopolysaccharides, amino acids, and short-chain fatty acids, whereas positive correlations between HOMA-IR and the peptidoglycan biosynthesis pathways were observed. In conclusion, insulin resistance was associated with decreased microbial α-diversity measures and abundance of genes related to the metabolic pathways. Our study provides a framework for understanding the microbial alterations in pediatric obesity.

7 August 2020 in Genes
Verified
Journal Article
Open access
PDF file
YPYe Peng
Ye Peng
QTQiming Tan
Qiming Tan
Shima AfhamiShima Afhami
Shima Afhami
Edward C. DeehanEdward C. Deehan
Edward C. Deehan
SLSuisha Liang
Suisha Liang
AHAndrea Haqq
Andrea Haqq
Although gut microbiota has been suggested to play a role in disease phenotypes of Prader–Willi syndrome (PWS), little is known about its composition in affected children and how it relates to hyperphagia. This cross-sectional study aimed to characterize the gut bacterial and fungal communities of children with PWS, and to determine associations with hyperphagia. Fecal samples were collected from 25 children with PWS and 25 age-, sex-, and body mass index-matched controls. Dietary intake data, hyperphagia scores, and relevant clinical information were also obtained. Fecal bacterial and fungal communities were characterized by 16S rRNA and ITS2 sequencing, respectively. Overall bacterial α-diversity and compositions of PWS were not different from those of the controls, but 13 bacterial genera were identified to be differentially abundant. Interestingly, the fungal community, as well as specific genera, were different between PWS and controls. The majority of the variation in the gut microbiota was not attributed to differences in dietary intake or the impact of genotype. Hyperphagia scores were associated with fungal α-diversity and relative abundance of several taxa, such as Staphylococcus, Clostridium, SMB53, and Candida. Further longitudinal studies correlating changes in the microbiome with the degree of hyperphagia and studies integrating multi-omics data are warranted.